Pimobendan
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11450 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | maternal uniparental disomy of chromosome 6 | KG + DL |
| 2 | autosomal recessive nonsyndromic deafness | KG + DL |
| 3 | autosomal dominant nonsyndromic deafness | KG + DL |
| 4 | keratoderma hereditarium mutilans | KG + DL |
| 5 | mullerian aplasia and hyperandrogenism | KG + DL |
| 6 | GM1 gangliosidosis | KG + DL |
| 7 | predisposition to invasive fungal disease due to CARD9 deficiency | KG + DL |
| 8 | asymmetric short stature syndrome | KG + DL |
| 9 | Fanconi anemia complementation group | KG + DL |
| 10 | portal hypertension, noncirrhotic | KG + DL |
| 11 | combined immunodeficiency due to ZAP70 deficiency | KG + DL |
| 12 | deafness, autosomal dominant | KG + DL |
| 13 | Brown syndrome | KG + DL |
| 14 | brachydactyly | KG + DL |
| 15 | tremor, hereditary essential | KG + DL |
| 16 | trichohepatoenteric syndrome | KG + DL |
| 17 | parastremmatic dwarfism | KG + DL |
| 18 | annular epidermolytic ichthyosis | KG + DL |
| 19 | hyperreflexia (disease) | KG + DL |
| 20 | cherubism | KG + DL |
| 21 | acral peeling skin syndrome | KG + DL |
| 22 | autosomal dominant vibratory urticaria | KG + DL |
| 23 | spondyloepiphyseal dysplasia with punctate corneal dystrophy | KG + DL |
| 24 | intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency | KG + DL |
| 25 | familial digital arthropathy-brachydactyly | KG + DL |
| 26 | xeroderma pigmentosum | KG + DL |
| 27 | TELO2-related intellectual disability-neurodevelopmental disorder | KG + DL |
| 28 | spasticity-ataxia-gait anomalies syndrome | KG + DL |
| 29 | congenital multicore myopathy with external ophthalmoplegia | KG + DL |
| 30 | progressive external ophthalmoplegia with mitochondrial DNA deletions | KG + DL |
| 31 | ectodermal dysplasia | KG + DL |
| 32 | hypogonadotropic hypogonadism with or without anosmia | KG + DL |
| 33 | cutis laxa, autosomal dominant | KG + DL |
| 34 | brachyolmia type 1, Hobaek type | KG + DL |
| 35 | potassium-aggravated myotonia | KG + DL |
| 36 | immunodeficiency | KG + DL |
| 37 | spongiform encephalopathy with neuropsychiatric features | KG + DL |
| 38 | Stüve-Wiedemann syndrome | KG + DL |
| 39 | Eiken syndrome | KG + DL |
| 40 | taurodontia-absent teeth-sparse hair syndrome | KG + DL |
| 41 | muscular dystrophy, progressive Pectorodorsal | KG + DL |
| 42 | Bruck syndrome | KG + DL |
| 43 | tooth agenesis, selective, X-linked, 1 | KG + DL |
| 44 | 3-hydroxy-3-methylglutaric aciduria | KG + DL |
| 45 | tarsal coalition | KG + DL |
| 46 | polycystic liver disease | KG + DL |
| 47 | isolated growth hormone deficiency | KG + DL |
| 48 | carnitine palmitoyl transferase 1A deficiency | KG + DL |
| 49 | spinal muscular atrophy-progressive myoclonic epilepsy syndrome | KG + DL |
| 50 | lissencephaly | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.